GRDN Guardian Pharmacy Services, Inc
$40.33▲ +1.95%
Healthcare
Other
After hours
$40.33▲ +0.00%
Oct 28, 4:01 PM ET
Volume 235.4K
Avg Volume (10D) 372.4K
Key Metrics & Fundamentals
Market Cap
$2.55B
P/E Ratio
39.2
Div Yield
0.00%
52W Range
26.34 - 48.33
% vs 50 MA
-1.49%
% vs 200 MA
6.18%
RSI-14
48.7
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.55
Free Cash Flow
$25.41M
Gross Rev
$351.77M
Gross Profit
$80.04M
EBITDA
$35.75M
COGS
$271.72M
Operating Exp
$59.40M
Operating Income
$20.64M
EBIT
$20.64M
Pretax Income
$29.79M
Net Income
$21.87M
EPS (Diluted)
0.34
Price & Volume History
Loading chart…
Recent News

Guardian Pharmacy Services (GRDN) Stock May Trade At a Discount Following a 38% Climb
Simply Wall St. · Oct 24, 2026 11:19 PM ET
Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call
Business Wire · Oct 21, 2026 4:30 PM ET

Zacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBF
Zacks · Sep 29, 2026 1:35 AM ET
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Zacks · Sep 28, 2026 7:52 AM ET
KeyBanc Initiates Guardian Pharmacy Services at Overweight With $52 Price Target
MT Newswires · Sep 23, 2026 6:46 AM ET
Truist Raises Price Target on Guardian Pharmacy Services to $51 From $47, Keeps Buy Rating
MT Newswires · Sep 21, 2026 6:46 AM ET
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy
MT Newswires · Sep 1, 2026 4:57 PM ET

Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Business Wire · Sep 1, 2026 4:30 PM ET
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Business Wire · Aug 19, 2026 4:30 PM ET

Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 7:44 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See GRDN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.